Aurinia Pharmaceuticals Inc (AUPH) — Capital Reinvestment Ratio
Aurinia Pharmaceuticals Inc (AUPH) has a Capital Reinvestment Ratio of 0.00x as of June 2026, meaning it reinvests 0% of its operating cash flow ($52.57 Million) in capital expenditures ($39.00K). Check AUPH tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aurinia Pharmaceuticals Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks Aurinia Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Aurinia Pharmaceuticals Inc.
Annual Capital Reinvestment Ratio for Aurinia Pharmaceuticals Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for Aurinia Pharmaceuticals Inc from 2024 to 2025. See how much free cash does Aurinia Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $135.66 Million | $252.00K | ▼ -70.7% |
| 2024 | 0.01x | $44.39 Million | $281.00K | — |